Patents Assigned to Glaukos Corporation
-
Patent number: 10828195Abstract: Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The shunts are preferably implanted by ab interno procedures.Type: GrantFiled: May 4, 2018Date of Patent: November 10, 2020Assignee: Glaukos CorporationInventors: Thomas W. Burns, David Haffner, Harold A. Heitzmann, Todd N. Fjield, Richard A. Hill
-
Patent number: 10828473Abstract: Systems and methods for treating ocular disorders are disclosed. One system has a delivery instrument, with a non-linear axis, configured to be inserted into an anterior chamber of an eye and moved to a location proximate a physiologic outflow pathway of the eye. The delivery instrument carries an implant that has a distal end sized for insertion into tissue such that aqueous humor drains from the anterior chamber to the physiologic outflow pathway. One method involves inserting a non-linear portion of a delivery device into the anterior chamber to position an implant within the eye. Another method involves using a delivery device with a curved distal portion to implant an implant at a location communicating with the physiologic outflow pathway. The delivery can be through a corneal incision and the implant can comprise a drug.Type: GrantFiled: May 29, 2018Date of Patent: November 10, 2020Assignee: Glaukos CorporationInventors: David Steven Haffner, Gregory T. Smedley, Hosheng Tu, Barbara A. Niksch, Richard A. Hill, Olav B. Bergheim
-
Patent number: 10674906Abstract: Gonioscope devices are disclosed herein that are configured to enable a medical professional to view structure inside the eye that is ordinarily hidden from normal view. The gonioscope can be an integrally molded single piece that includes both a handle and a gonioscopic optical element. The proximal surface can have a viewing area and a light diffusing area. A recess can provide access to a wound site on the eye while the gonioscope is used for viewing. The handle can be configured to encourage proper alignment of the gonioscope with the eye. The gonioscope can provide an optical fixation point for the subject to focus on to facilitate proper alignment of the eye. The gonioscope can have one or more retention elements configured to engage the tissue of the eye around the contact surface to stabilize the gonioscope. The gonioscope can couple to a lid speculum.Type: GrantFiled: February 22, 2018Date of Patent: June 9, 2020Assignee: GLAUKOS CORPORATIONInventors: Charles Raymond Kalina, Jr., Huong Khac Huynh, Douglas Daniel Crimaldi, Todd N. Fjield
-
Patent number: 10568762Abstract: Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.Type: GrantFiled: April 23, 2019Date of Patent: February 25, 2020Assignee: GLAUKOS CORPORATIONInventors: Mary G. Lynch, Reay H. Brown
-
Patent number: 10517759Abstract: The invention relates generally to medical devices and methods for reducing the intraocular pressure in an animal eye and, more particularly, to stent type devices for permitting aqueous outflow from the eye's anterior chamber and associated methods thereof for the treatment of glaucoma. Some aspects provide a self-trephining glaucoma stent and methods thereof which advantageously allow for a “one-step” procedure in which the incision and placement of the stent are accomplished by a single device and operation. This desirably allows for a faster, safer, and less expensive surgical procedure.Type: GrantFiled: March 12, 2014Date of Patent: December 31, 2019Assignee: GLAUKOS CORPORATIONInventors: Douglas Daniel Crimaldi, Charles Raymond Kalina, Jr.
-
Patent number: 10499809Abstract: A gonioscopic attachment can attach to a gonioscope and can include atraumatic retention elements that are configured to engage an eye to retain the gonioscope relative to the eye. The gonioscopic attachment can be configured to position the gonioscope so that at least a portion of the concave distal surface of the gonioscopic optical element is spaced apart from the eye, and/or so that the curvature of the distal surface is angularly offset from the curvature of the eye. The gonioscope can include a fixation point configured to be visible to the subject when the gonioscope is positioned on the eye. In some embodiments, the retention elements can be incorporated directly into the gonioscope. A coupling mechanism can couple the gonioscope to a lid speculum. The gonioscope can include a light pipe, which can be configured to directly light into the eye.Type: GrantFiled: March 18, 2016Date of Patent: December 10, 2019Assignee: Glaukos CorporationInventors: Charles Raymond Kalina, Jr., Thomas W. Burns, Chris Calcaterra, Edward Collins, Timothy McCauley, David S. Haffner, Steven M. Henderson
-
Patent number: 10492950Abstract: Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.Type: GrantFiled: November 22, 2017Date of Patent: December 3, 2019Assignee: GLAUKOS CORPORATIONInventors: Mary G. Lynch, Reay H. Brown
-
Patent number: 10485702Abstract: Surgical methods and related medical devices for treating ocular disorders are disclosed. Some methods relate to delivering an implant within an eye, and involve providing an elongate guide device, such as, a flexible guide member or a guide wire. A distal end of the guide device can be advanced into an anterior chamber of an eye, or through at least a portion of a site of resistance along a physiologic outflow pathway of the eye, or from an anterior chamber of the eye to a location proximate a physiologic outflow pathway of the eye. The implant is advanced along the guide device toward the guide device distal end, and is positioned to conduct aqueous humor between the anterior chamber and the physiologic outflow pathway.Type: GrantFiled: June 8, 2018Date of Patent: November 26, 2019Assignee: GLAUKOS CORPORATIONInventors: Olav B. Bergheim, Morteza Gharib, Richard A. Hill
-
Patent number: 10485701Abstract: Intraocular stents and applicators are disclosed for treating glaucoma. The stents are configured to extend between the anterior chamber of the eye and Schlemm's canal for enhancing outflow of aqueous from the anterior chamber so as to reduce intraocular pressure. The stents can have features for anchoring the stent into Schlemm's canal as well as preventing the walls of Schlemm's canal from closing the outlet of the stents. The applicators can be steerable so as to make implantation easier. Additionally, the applicators can be configured to hold a plurality of stents so that multiple stents can be implanted through one incision without removing the applicator from the incision between serial implantations.Type: GrantFiled: March 20, 2017Date of Patent: November 26, 2019Assignee: Glaukos CorporationInventors: David Steven Haffner, Gregory T. Smedley, Hosheng Tu, Thomas W. Burns
-
Patent number: 10406029Abstract: Ocular implants, delivery devices and methods for treating ocular disorders are disclosed. One method involves inserting an implant on one side of an eye. The implant has an anchor on a distal end portion and an outlet opening that is disposed proximal of the anchor. The implant is advanced across the eye to the other side of the eye. The anchor is inserted into eye tissue on the other side of the eye. A therapeutic agent is eluted using the implant.Type: GrantFiled: October 12, 2015Date of Patent: September 10, 2019Assignee: Glaukos CorporationInventors: Hosheng Tu, Jason Artof, David Steven Haffner, Gregory T. Smedley, Barbara A. Niksch
-
Patent number: 10285856Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involves bypassing diseased trabecular meshwork with the use of a stent implant. The stent implant is inserted into an opening created in the trabecular meshwork by a piercing member that is slidably advanceable through the lumen of the stent implant for supporting the implant insertion. The stent implant is positioned through the trabecular meshwork so that an inlet end of the stent implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: GrantFiled: February 6, 2017Date of Patent: May 14, 2019Assignee: Glaukos CorporationInventors: Hosheng Tu, David Steven Haffner, Gregory T. Smedley, Barbara A. Niksch, Morteza Gharib, Thomas W. Burns, Richard Lindstrom
-
Patent number: 10285853Abstract: Delivery devices, systems and methods are provided for inserting an implant into an eye. The delivery or inserter devices or systems can be used to dispose or implant an ocular stent or implant, such as a shunt, in communication with a suprachoroidal space of the eye. The implant can drain fluid from an anterior chamber of the eye to a physiologic outflow path of the eye, such as, the suprachoroidal space or other portion of the uveoscleral outflow path. The delivery or inserter devices or systems can be used in conjunction with other ocular surgery, for example, but not limited to, cataract surgery-through a preformed corneal incision, or independently with the inserter configured to make a corneal incision. The implant can be preloaded with or within the inserter to advantageously provide a sterile, easy-to-use package for use by an operator.Type: GrantFiled: March 12, 2014Date of Patent: May 14, 2019Assignee: Glaukos CorporationInventors: Gary Rangel-Friedman, David S. Haffner
-
Patent number: 10271989Abstract: Systems and methods for delivering multiple ocular implants to reduce intraocular pressure are disclosed. The ocular implants can be implanted at multiple sites within a single human eye without requiring removal of the delivery apparatus from the eye. A system for delivering multiple ocular implants can include at least two implants preloaded within a delivery device and configured to be implanted within the eye, a metering device configured to transfer energy to the implants for delivery at selected locations within the eye, wherein the metering device is configured to meter a variable amount of energy for each implant delivery event in the eye. The system can further include an injector mechanism configured to serially engage and drive each of the implants.Type: GrantFiled: October 30, 2015Date of Patent: April 30, 2019Assignee: Glaukos CorporationInventors: David Steven Haffner, Henrick K. Gille, Charles Raymond Kalina, Jr., John Joseph Cogger
-
Patent number: 10245178Abstract: Disclosed herein are drug delivery ocular implants comprising an elongate outer shell having a proximal end, and distal end and being shaped to define an interior lumen, at least one therepautic agent positioned within the lumen, wherein the outer shell has at least a first thickness, the outer shell comprises one or more regions of drug release, and the implant is dimensioned for implantation within the anterior chamber of the eye.Type: GrantFiled: June 6, 2012Date of Patent: April 2, 2019Assignee: Glaukos CorporationInventors: Harold Heitzmann, Vanessa Tasso
-
Patent number: 10188551Abstract: Delivery devices, systems and methods are provided for inserting an implant into an eye. The delivery or inserter devices or systems can be used to dispose or implant an ocular stent or implant, such as a shunt, in communication with the suprachoroidal space, uveal scleral outflow pathway, uveoscleral outflow path or supraciliary space of the eye. The implant can drain fluid from an anterior chamber of the eye to a physiologic outflow path of the eye, such as, the suprachoroidal space, uveal scleral outflow pathway, uveoscleral outflow path or supraciliary space. Alternatively, or in addition, the implant can elute a drug or therapeutic agent. The delivery or inserter devices or systems can be used in conjunction with other ocular surgery, for example, but not limited to, cataract surgery through a preformed corneal incision, or independently with the inserter configured to make a corneal incision.Type: GrantFiled: March 13, 2017Date of Patent: January 29, 2019Assignee: GLAUKOS CORPORATIONInventors: Gary Rangel-Friedman, David Steven Haffner
-
Patent number: 9993368Abstract: Surgical methods and related medical devices for treating ocular disorders are disclosed. Some methods relate to delivering an implant within an eye, and involve providing an elongate guide device, such as, a flexible guide member or a guide wire. A distal end of the guide device can be advanced into an anterior chamber of an eye, or through at least a portion of a site of resistance along a physiologic outflow pathway of the eye, or from an anterior chamber of the eye to a location proximate a physiologic outflow pathway of the eye. The implant is advanced along the guide device toward the guide device distal end, and is positioned to conduct aqueous humor between the anterior chamber and the physiologic outflow pathway.Type: GrantFiled: October 28, 2010Date of Patent: June 12, 2018Assignee: Glaukos CorporationInventors: Olav B. Bergheim, Morteza Gharib, Richard A. Hill
-
Patent number: 9987472Abstract: Systems and methods for treating ocular disorders are disclosed. One system has a delivery instrument, with a non-linear axis, configured to be inserted into an anterior chamber of an eye and moved to a location proximate a physiologic outflow pathway of the eye. The delivery instrument carries an implant that has a distal end sized for insertion into tissue such that aqueous humor drains from the anterior chamber to the physiologic outflow pathway. One method involves inserting a non-linear portion of a delivery device into the anterior chamber to position an implant within the eye. Another method involves using a delivery device with a curved distal portion to implant an implant at a location communicating with the physiologic outflow pathway. The delivery can be through a corneal incision and the implant can comprise a drug.Type: GrantFiled: December 27, 2010Date of Patent: June 5, 2018Assignee: GLAUKOS CORPORATIONInventors: Hosheng Tu, Gregory T. Smedley, David Steven Haffner, Barbara A. Niksch, Richard A. Hill, Olav B. Bergheim
-
Patent number: D833008Type: GrantFiled: February 27, 2017Date of Patent: November 6, 2018Assignee: Glaukos CorporationInventors: Charles Raymond Kalina, Jr., Huong Khac Huynh
-
Patent number: D846738Type: GrantFiled: October 27, 2017Date of Patent: April 23, 2019Assignee: GLAUKOS CORPORATIONInventors: Charles Raymond Kalina, Jr., James Robert Dennewill, Sr.
-
Patent number: D886997Type: GrantFiled: September 25, 2018Date of Patent: June 9, 2020Assignee: GLAUKOS CORPORATIONInventors: Charles Raymond Kalina, Jr., Huong Khac Huynh